Influenza virus recombinant X-53 produced for use in the 1976 National Immunization Program for swine influenza was found to comprise two types of virions differing in their antigenic, replicative, and plaque-forming characteristics. One type, characteristic of X-53 and designated "L," was relatively low-yielding in chicken embryos, produced small clear plaques in Madin-Darby dog kidney cells, and was selectively inhibited by heterotypic antibody to the A/sw/Cam/39 strain of swine influenza virus. The other, X-53a or "H," was high-yielding in chicken embryos, produced large turbid plaques in dog kidney cells, and was not inhibited by concentrations of A/sw/Cam/39 antisera inhibitory to X-53. It was shown that A/NJ/11/76 (HswN1) virus, from which X-53 was derived, and five other swine influenza virus isolates from humans and pigs were dimorphic mixtures of the two types of virus. Segregation of the hemagglutinin genes of L and H variants by further recombination demonstrated that their different properties were pleiotropic phenotypes of mutation in the hemagglutinin gene. Under selective conditions suppressive to the L mutant, mutation of cloned L to H virus was observed. This observation, as well as the apparent ubiquity of the two mutants in nature, suggests that this is another example of viral dimorphism-the stable association of two allelic mutants. Of special significance is the indication that antigenic variants may be selected by selection for properties other than antigenicity, and therefore may represent mutants with pathogenic effects determined by factors other than lesser modulation by host antibody.
Hemagglutinins, Viral Influenza A virus